4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid CAS NO.641569-94-0
- FOB Price: USD: 1.00-100.00 / Get Latest Price
- Min.Order: 0
- Payment Terms: L/C|T/T|Westem Union||Other
- Product Details
Keywords
Quick Details
- ProName: 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimid...
- CasNo: 641569-94-0
- Molecular Formula: C17H14N4O2
- Appearance: White Powder
- Application: Intermediate for Erlotinib
- DeliveryTime: Min 3 Days
- PackAge: Bag/Drum
- Port: Chengdu
- ProductionCapacity: 5 Metric Ton/Year
- Purity: 99.0%
- Storage: In Cool Place
- Transportation: Air/Sea
- LimitNum: 0
Superiority
Erlotinibhydrochloride(tradenameTarceva)isadrugusedtotreatnon-smallcelllungcancer,pancreaticcancerandseveralothertypesofcancer.Itisareve
Details
Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer, pancreatic cancer and several other types of cancer. It is a reversible tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). It is marketed in the United Statesby Genentech and OSI Pharmaceuticals and elsewhere by Roche. In lung cancer, it extends life by an average of 3.3 months.[citation
Mechanism[edit]
Erlotinib is an EGFR inhibitor. The drug follows Iressa (gefitinib), which was the first drug of this type. Erlotinib specifically targets the epidermal growth factor recept